Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License. ​All of our articles are available to download individually in PDF format.


Session One: Basal Insulins: Still Innovating After All These Years

Session One: Basal Insulins: Still Innovating After All These Years

October 31, 2017 at 8:29 AM 0 comments

This Sanofi sponsored symposium, titled ‘Evolving Standards and Innovation in Diabetes Care’, took place on 11th September 2017, as part of the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Lisbon, Portugal. Symposium Chair: Elizabeth Seaquist1 Session Chair: Robert Ritzel2 Speakers: Jeremy Pettus,3 Kamlesh Khunti4Read More

Session Two: Changing the Type 2 Diabetes Mellitus Management Paradigm with Fixed-Ratio Combinations

Session Two: Changing the Type 2 Diabetes Mellitus Management Paradigm with Fixed-Ratio Combinations

October 31, 2017 at 8:28 AM 0 comments

This Sanofi sponsored symposium, titled ‘Evolving Standards and Innovation in Diabetes Care’, took place on 11th September 2017, as a part of the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Lisbon, Portugal Symposium Chair: Elizabeth Seaquist1 Session Chair: Julio Rosenstock2 Speakers: James R. Gavin III,3 Neil Skolnik,4 LuciaRead More

Session Three: Innovating Beyond Glucose Control in Diabetes Care

Session Three: Innovating Beyond Glucose Control in Diabetes Care

October 31, 2017 at 8:27 AM 0 comments

This Sanofi sponsored symposium, titled ‘Evolving Standards and Innovation in Diabetes Care’, took place on 11th September 2017 as part of the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Lisbon, Portugal Symposium Chair: Elizabeth Seaquist1 Session Chair: Thomas Danne2 Speakers: Dirk Müller-Wieland,3 Lawrence A.Read More

Editor’s Pick: Addressing Hypertension in the Patient with Type 2 Diabetes Mellitus: Pathogenesis, Goals, and Therapeutic Approach

Editor’s Pick: Addressing Hypertension in the Patient with Type 2 Diabetes Mellitus: Pathogenesis, Goals, and Therapeutic Approach

October 31, 2017 at 8:26 AM 0 comments

The Editor’s Pick for this issue is an informative review from Ali A. Rizvi on hypertension in patients with Type 2 diabetes mellitus and considers the pathogenesis, goals, and therapeutic approaches to managing this comorbidity. There have been many clinical trials in this area and this paper discusses the outcomesRead More

Future Treatments of Diabetic Retinopathy: Pharmacotherapeutic Products Under Development

Future Treatments of Diabetic Retinopathy: Pharmacotherapeutic Products Under Development

October 31, 2017 at 8:25 AM 0 comments

*Michael W. Stewart Mayo Clinic School of Medicine, Jacksonville, Florida, USA *Correspondence to stewart.michael@mayo.edu Disclosure: The author has received institutional research support from Allergan and Regeneron, and has acted as a consultant for Alkahest and Bayer. Received: 20.05.17 Accepted: 18.09.17 Citation: EMJ Diabet. 2017;5[1]:93-103. Abstract Diabetic macular oedema (DMO) isRead More

Role of Probiotics in Diabetes: A Review of Their Rationale and Efficacy

Role of Probiotics in Diabetes: A Review of Their Rationale and Efficacy

October 31, 2017 at 8:24 AM 0 comments

Neel Jayesh Shah, *Onkar C. Swami Unichem Laboratories Ltd, Mumbai, Maharashtra, India *Correspondence to onkar.swami@unichemlabs.com Disclosure: The authors have declared no conflicts of interest. Received: 23.02.17 Accepted: 07.09.17 Citation: EMJ Diabet. 2017;5[1]:104-110. Abstract The commensal bacteria that are present in our body since infancy are known to play a roleRead More

Type 2 Diabetes Mellitus and Stem Cell Therapy: A Review

Type 2 Diabetes Mellitus and Stem Cell Therapy: A Review

October 31, 2017 at 8:23 AM 0 comments

*Tarek W. Wehbe,1 Tatiana B. Hawat2 1. Hematology Department, The Lebanese Canadian Hospital, Sin El-Fil, Lebanon; Notre Dame University Hospital, Jounieh, Lebanon 2. Saint George Hospital, University Medical Center, Balamand Medical School, Beirut, Lebanon *Correspondence to twwehbe4@gmail.com Disclosure: The authors have declared no conflicts of interest. Acknowledgements: The authors would likeRead More

Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Effective?

Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Effective?

October 31, 2017 at 8:22 AM 0 comments

Kuan Hao Yee,1 *Srinivasan Sanjay2,3 1. College of Medicine, Nursing & Health Sciences, National University of Ireland (Galway), Galway, Ireland 2. Yong Loo Lin School of Medicine, National University of Singapore, Singapore 3. Department of Ophthalmology and Visual Sciences, Khoo Teck Puat Hospital, Singapore *Correspondence to sanjay_s@alexandrahealth.sg Disclosure: The authorsRead More

Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Safe?

Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Oedema: Is It Safe?

October 31, 2017 at 8:21 AM 0 comments

Kuan Hao Yee,1 *Srinivasan Sanjay2,3 1. College of Medicine, Nursing & Health Sciences, National University of Ireland, Galway, Ireland 2. Yong Loo Lin School of Medicine, National University of Singapore, Singapore 3. Department of Ophthalmology and Visual Sciences, Khoo Teck Puat Hospital, Singapore *Correspondence to sanjay_s@alexandrahealth.sg Disclosure: The authors haveRead More

Cardiovascular Risk Factor Control in Type 2 Diabetes Mellitus and New Trial Evidence

Cardiovascular Risk Factor Control in Type 2 Diabetes Mellitus and New Trial Evidence

March 2, 2017 at 8:20 AM 0 comments

*Peter M. Nilsson Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden *Correspondence to Peter.Nilsson@med.lu.se Disclosure: The author has declared no conflicts of interest. Acknowledgements: The review was supported by a grant from the Research Council and the Heart and Lung Foundation of Sweden. Received: 19.09.16 Accepted: 28.11.16Read More